Health Care Reform

The plaintiff wants to represent a class of enrollees who suffer from the 'disability' of obesity.

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal blood sugar.

She's once again calling for HHS to exercise "march-in" rights, which let the government create alternatives to patented items.

While the ruling does not derail the Medicare drug negotiation program, which drugmakers have already agreed to prices for the first 10 drugs selected for the first round, it sends the case back to a lower court for consideration.

The PBMs say out-of-pocket insulin costs have fallen sharply since 2019.

The industry is reaching a tipping point where an increasingly loud chorus of voices are demanding transparency and a focus on health strategy.